false
0001130166
0001130166
2026-08-12
2026-08-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
August
12, 2026
Date
of Report (date of earliest event reported)

Bio
Green Med Solution, Inc.
(Exact
name of Registrant as specified in its charter)
| Delaware |
|
0-50626 |
|
91-1707622 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
Number) |
Level
10, Tower 11, Avenue 5, No. 8
Jalan
Kerinchi, Kuala Lumpur, Malaysia 59200
(Address
of principal executive offices) (Zip code)
(908)
955-0526
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
BGMS |
|
The
Nasdaq Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02. Results of Operations and Financial Condition.
and
Item
7.01. Regulation FD Disclosure.
The
following information is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item
7.01, “Regulation FD Disclosure”, and shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
On
August 12, 2026, Bio Green Med Solution Inc. issued a press release setting forth its second quarter 2026 results. A copy of the press
release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.
Item
9.01. Financial Statements and Exhibits.
| Exhibit
No. |
|
Exhibit |
| 99.1 |
|
Press Release of Bio Green Med Solution, Inc. dated August 12, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| Date: August
13, 2026 |
Bio Green Med Solution, Inc. |
| |
|
|
| |
By: |
/s/
Datuk Dr. Doris Wong Sing Ee |
| |
Name:
|
Datuk
Dr. Doris Wong Sing Ee |
| |
Title: |
Chief
Executive Officer and Executive Director |
Exhibit
99.1
BIO
GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update
KUALA
LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”),
a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second
quarter financial results and provided a business update.
Highlights
of the second quarter ended June 30, 2026, or in some cases shortly thereafter, include:
| ● | In
June, the Company, Future NRG Sdn. Bhd., a Malaysia private limited company (“FNRG”)
and each of the shareholders of FNRG (the “Selling Shareholders”), entered into
a Business Combination Agreement (the “BCA”), pursuant to which, among other
matters, and subject to the satisfaction or waiver of the conditions set forth in the BCA,
the Selling Shareholders will voluntarily exchange all of their ordinary shares in FNRG for
shares of common stock, par value $0.001 of the Company (the “Exchange Shares”),
resulting in FNRG becoming a wholly owned subsidiary of the Company (the “Exchange”).
Subject to the terms and conditions of the BCA, at the closing of the Exchange: (a) each
then-outstanding ordinary share of FNRG will be converted into the right to receive a number
of Exchange Shares calculated in accordance with the BCA. Under the exchange ratio formula
in the BCA, upon the closing of the Exchange, on a pro forma basis and based upon the number
of Exchange Shares to be issued in the Exchange, the Selling Shareholders will own approximately
more than 99% of the combined company and pre-Exchange Company stockholders will own approximately
less than 1% of the combined company. The BCA contains certain termination rights of each
of the Company and FNRG. In the event the Exchange is not closed by December 31, 2026, either
party may terminate the BCA and the transactions contemplated thereunder. |
| ● | In
June, the Company entered into a Securities Purchase Agreement with certain foreign accredited
investors, pursuant to which the investors agreed to purchase from the Company an aggregate
of 1,103,338 shares of Common Stock, par value $0.001 of the Company at a purchase price
of $0.72 per share for aggregate gross proceeds of $794,403, subject to the terms and conditions
of the Purchase Agreement. |
| ● | In
July, the Board of Directors of the Company declared a quarterly cash dividend of $0.15 per
share on the Company’s 6% Convertible Exchangeable Preferred Stock, which cash dividend
was paid on August 1, 2026, to holders of record as of the close of business on July 23,
2026; |
Financial
Highlights
As
of June 30, 2026, cash and cash equivalents totaled $3.8 million, compared to $3.5 million as of December 31, 2025.
Net
cash used in operating activities was $0.4 million for the three months ended June 30, 2026. The Company estimates that its current cash
resources will fund planned expenditure into the first quarter of 2027.
Following
the acquisition of Fitters Sdn. Bhd. on September 12, 2025, product revenue from sales and distribution of fire safety equipment was
$336,000 for the three months ended June 30, 2026.
Cost
of sales related to sales and distribution of fire safety equipment was $257,000 for the three months ended June 30, 2026, yielding a
gross margin of approximately 23%
General
and administrative expenses decreased by approximately $0.7 million from $1.2 million for the three months ended June 30, 2025 to $0.5
million for the three months ended June 30, 2026, due to several one-time costs associated with the two changes of control of the Company
during 2025 and lower operating costs of the company under current management.
Total
other income, net, for the three months ended June 30, 2026, increased by approximately $21,000 from $1,000 for the three months ended
June 30, 2025 to $22,000 for the three months ended June 30, 2026, due largely to foreign exchange gains.
Income
tax provision for the three months ended June 30, 2026, increased by approximately $7,000, from $2,000 for the three months ended June
30, 2025 to $9,000 for the three months ended June 30, 2026 and related to our fire safety business, acquired in September 2025.
Net
loss from discontinued operations was $68,000 for the three months ended June 30, 2025 and is related to our former operations from biopharmaceutical
activities. There was no activity from discontinued operations in the current period.
Net
loss for the three months ended June 30, 2026, was $0.4 million, compared to $1.3 million for the same period in 2025.
About
Bio Green Med Solution, Inc.
BGMS
is a diversified company that was formerly engaged in
the biopharmaceutical industry but as of September 2025 has shifted its operations to focus on provision of fire safety protection and
distribution activities. Specifically, on September 12, 2025, the Company completed its acquisition of Fitters Sdn. Bhd., a Malaysia-based
group specializing in fire protection products and services. Headquartered in Malaysia, the Company is now focused on advancing opportunities
across these distinct sectors whilst maintaining its commitment to driving long-term value creation for shareholders. For
additional information, please visit www.bgmsglobal.com.
Forward-looking
Statements
Except
for historical information, certain matters discussed in this press release may be “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance
and involve various assumptions, known and unknown risks, uncertainties and other factors that may cause our actual results, levels of
activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements
expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by words such as
“may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential” or other comparable words. Actual results,
performance or outcomes may differ materially from those expressed or implied by these forward-looking statements and may not align with
historical performance and events due to a number of factors, including those discussed in the sections of our annual report on Form
10-K entitled “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors,” and those discussed
in our Form 10-Q quarterly reports filed after such annual report. BGMS’s SEC filings are readily obtainable at no charge at www.sec.gov,
as well as on its own investor relations website at https://investor.bgmsglobal.com/sec-filings. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance
or achievements, and caution should be exercised against placing undue reliance upon such statements, which are based only on information
currently available to us and speak only as of the date hereof. We are under no duty to update publicly any of the forward-looking statements
after the date of this earnings press release, whether as a result of new information, future events or otherwise, except as required
by law.
SOURCE:
Bio
Green Med Solution, Inc.
info@bgmsglobal.com
BIO
GREEN MED SOLUTION, INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS (LOSS)
(In
$000s, except share and per share amounts)
| | |
Three Months Ended | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Revenues: | |
| | | |
| | |
| Product revenue - fire safety | |
$ | 336 | | |
$ | - | |
| Revenues | |
$ | 336 | | |
$ | - | |
| | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | |
| Cost of sales | |
| 257 | | |
| - | |
| General and administrative | |
| 497 | | |
| 1,249 | |
| Total operating expenses | |
| 754 | | |
| 1,249 | |
| Operating loss | |
| (418 | ) | |
| (1,249 | ) |
| Other income (expense): | |
| | | |
| | |
| Foreign exchange gains (losses) | |
| (18 | ) | |
| (3 | ) |
| Interest income | |
| 9 | | |
| 2 | |
| Other income, net | |
| 31 | | |
| 2 | |
| Total other income, net | |
| 22 | | |
| 1 | |
| Loss from continuing operations before taxes | |
| (396 | ) | |
| (1,248 | ) |
| Income tax provision | |
| (9 | ) | |
| (2 | ) |
| Net loss from continuing operations | |
| (405 | ) | |
| (1,250 | ) |
| Discontinued operations: | |
| | | |
| | |
| Operating losses from discontinued operations | |
| - | | |
| (68 | ) |
| Net income from discontinued operations | |
| - | | |
| (68 | ) |
| Net loss | |
| (405 | ) | |
| (1,318 | ) |
| Dividend on convertible exchangeable preferred shares | |
| (20 | ) | |
| (20 | ) |
| Net loss applicable to common shareholders | |
$ | (425 | ) | |
$ | (1,338 | ) |
| Basic and diluted earnings per common share: | |
| | | |
| | |
| Net loss per share, continuing operations – basic and diluted (common shareholders) | |
$ | (0.08 | ) | |
$ | (0.93 | ) |
| Net income per share, discontinued operations – basic and diluted (common shareholders) | |
$ | - | | |
$ | (0.05 | ) |
| | |
| | | |
| | |
| Weighted average common shares outstanding | |
| 5,598,701 | | |
| 1,360,626 | |
BIO
GREEN MED SOLUTION, INC.
CONSOLIDATED
BALANCE SHEET
(In
$000s, except share, per share, and liquidation preference amounts)
| | |
June 30, 2026 | | |
December 31, 2025 | |
| | |
| | |
| |
| ASSETS | |
| | | |
| | |
| Current assets: | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 3,790 | | |
$ | 3,505 | |
| Inventory | |
| 972 | | |
| 1,384 | |
| Accounts receivable | |
| 1,074 | | |
| 1,257 | |
| Prepaid expenses and other current assets | |
| 133 | | |
| 110 | |
| Total current assets | |
| 5,969 | | |
| 6,256 | |
| | |
| | | |
| | |
Property and equipment, net Property and equipment, net | |
| 136 | | |
| 137 | |
| Right-of-use lease asset | |
| 7 | | |
| 12 | |
| Goodwill | |
| 1,570 | | |
| 1,570 | |
Property and equipment, net Non-current deposits | |
| 172 | | |
| 210 | |
| Total assets | |
$ | 7,854 | | |
$ | 8,185 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Accounts payable | |
$ | 189 | | |
$ | 617 | |
| Accrued and other current liabilities | |
| 503 | | |
| 715 | |
| Total current liabilities | |
| 692 | | |
| 1,332 | |
| Lease liability | |
| - | | |
| 2 | |
| Other liabilities | |
| 2 | | |
| 9 | |
| Total liabilities | |
| 694 | | |
| 1,343 | |
| | |
| | | |
| | |
| Stockholders’ equity | |
| 7,160 | | |
| 6,842 | |
| Total liabilities and stockholders’ equity | |
$ | 7,854 | | |
$ | 8,185 | |